| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/04/2011 | CN101091706B Excitant of dopamine transport protein and usage |
| 05/04/2011 | CN101084968B Health care food for increasing bone density |
| 05/04/2011 | CN101073575B Capsule for treating acne |
| 05/04/2011 | CN101072784B Derivatives of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl]phosphonic acid and methods of making them |
| 05/04/2011 | CN101070308B Isoxazoline derivative and its use |
| 05/04/2011 | CN101057913B New medical use of vitex and method for preparing medicinal intermediate |
| 05/04/2011 | CN101032483B Hydantoin derivative for adjusting estrogen receptor activity and application thereof |
| 05/04/2011 | CN101014580B Morpholine compound |
| 05/04/2011 | CN101011483B Chinese medicinal formulation for treating children's digestive system disease and its preparation method |
| 05/04/2011 | CN101007052B An antitumor medicine and its preparation method |
| 05/04/2011 | CN100998594B Solid oral medicine composition containing amodiaquine |
| 05/03/2011 | USRE42327 Medicinal compositions improving brain function and method for improving brain function |
| 05/03/2011 | US7935853 Micronized composition of a 2,4-disubstituted phenol derivative |
| 05/03/2011 | US7935848 Butone derivatives useful as cooling agents |
| 05/03/2011 | US7935839 Sepsis treatment methods |
| 05/03/2011 | US7935832 Pyrrole and isoindole carboxamide derivatives as P2X7 modulators |
| 05/03/2011 | US7935825 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain |
| 05/03/2011 | US7935823 Fluoro-containing derivatives of hydrogenated pyrido[4,3-b]indoles with neuroprotective and cognition enhancing properties, process for preparing, and use |
| 05/03/2011 | US7935817 Salt form and cocrystals of adefovir dipivoxil and processes for preparation thereof |
| 05/03/2011 | US7935811 Apparatus and system having dry gene silencing compositions |
| 05/03/2011 | US7935787 Formulations which stabilize and inhibit precipitation of immunogenic compositions |
| 05/03/2011 | US7935732 Antimicrobial compositions |
| 05/03/2011 | US7935731 Methods for concomitant administration of colchicine and macrolide antibiotics |
| 05/03/2011 | US7935729 Use of triglyceride oils containing γ-linolenic acid residues and linoleic acid residues for the treatment of neurodegenerative disease |
| 05/03/2011 | US7935728 Cyclic palladium compounds having coordinated thereto bis (diphenylphosphine) ferrocene ligands which inhibit the activity of proteins and enzymes and treatment of diseases and disorders associated therewith |
| 05/03/2011 | US7935727 CETP inhibitors |
| 05/03/2011 | US7935726 Tricyclic pyrones |
| 05/03/2011 | US7935725 Aryl-substituted bridged or fused diamines as modulators of leukotriene A4 hydrolase |
| 05/03/2011 | US7935724 Thiophene and benzothiophene hydroxamic acid derivatives |
| 05/03/2011 | US7935723 Use of organic compounds |
| 05/03/2011 | US7935722 Tetrahydrocarbazole derivatives useful as androgen receptor modulators |
| 05/03/2011 | US7935721 Spiro-oxindole compounds and their uses as therapeutic agents |
| 05/03/2011 | US7935720 Crystal of substituted phenylalkanoic acid ester and process for producing the same |
| 05/03/2011 | US7935719 N-substituted-azacyclylamines as histamine-3 antagonists |
| 05/03/2011 | US7935718 Treatment of dyskinesia |
| 05/03/2011 | US7935717 Prevent diseases of vascular system, oxidative stresses; controlling concentration of prostaglandin 12; anticholesterol agents; insulin resistance; antidiabetic agents; antiinflammatory agents ; antiarthritic agents; thrombosis; adult respiratory distress syndrome ; neurodegenerative diseases |
| 05/03/2011 | US7935715 Compounds which modulate the CB2 receptor |
| 05/03/2011 | US7935714 Compositions for sleeping disorders |
| 05/03/2011 | US7935713 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use |
| 05/03/2011 | US7935712 Spirochromanone derivatives as acetyl coenzyme A carboxylase (ACC) inhibitors |
| 05/03/2011 | US7935711 Mixing of active material with carrier; viricides |
| 05/03/2011 | US7935710 Microbicidal pyrimidine or triazine for preventing sexual HIV transmission |
| 05/03/2011 | US7935709 2-quinazolinone compounds and methods of use |
| 05/03/2011 | US7935708 Dihydropyrazolopyrimidinone derivatives |
| 05/03/2011 | US7935707 Imidazole derivatives |
| 05/03/2011 | US7935706 Nitrogen-containing heterocycle derivatives substituted with cyclic group |
| 05/03/2011 | US7935704 antiproliferative, antitumor agent; fungicide; inhibit eukaryotic cell cycle progression in M phase; rheumatoid arthritis, chronic articular rheumatism, psoriasis, diabetic retinopathy, neovascular glaucoma, retinopathy of prematurity, macular degeneration, corneal graft rejection, osteoporosis |
| 05/03/2011 | US7935703 Piperazines and piperidines as Mglur5 potentiators |
| 05/03/2011 | US7935702 Substituted biaryl quinolin-4-ylamine analogues |
| 05/03/2011 | US7935701 Microbicidal composition based on formaldehyde donor compounds and antioxidants |
| 05/03/2011 | US7935700 Morpholine compound |
| 05/03/2011 | US7935699 Pyrazole glucokinase activators |
| 05/03/2011 | US7935698 Heteroaryl-hydrazone compounds |
| 05/03/2011 | US7935697 Compositions for modulating a kinase cascade and methods of use thereof |
| 05/03/2011 | US7935696 e.g. 5-(4-Chlorophenyl)-N-(5-(cyclopropylcarbamoyl)-2-methylphenyl)furan-2-carboxamide; p38 alpha and beta kinase inhibitor; antiinflammatory agent; asthma, inflammatory bowel disease, osteoporosis, psoriasis, graft vs. host rejection, atherosclerosis, multiple myeloma, pain, myocardial ischemia |
| 05/03/2011 | US7935695 1,4-diaza-bicyclo[3.2.2]nonyl heteroaryl derivatives useful as nicotinic acetylcholine receptor ligands |
| 05/03/2011 | US7935693 Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as Axl inhibitors |
| 05/03/2011 | US7935692 Polyamine compounds are used to mobilize and harvest CD34+ cells via apheresis with and without combinations with other mobilizing factors; bind to chemokine receptors; regeneration of heart tissue |
| 05/03/2011 | US7935691 Extended cycle multiphasic oral contraceptive kit |
| 05/03/2011 | US7935690 Pharmaceutical composition |
| 05/03/2011 | US7935689 Compounds for the treatment of metabolic disorders |
| 05/03/2011 | US7935688 Vitamin D-like compound |
| 05/03/2011 | US7935687 Methods for treating spinal muscular atrophy using tetracycline compounds |
| 05/03/2011 | US7935686 Acyloxyalkyl carbamate prodrugs, methods of synthesis, and use |
| 05/03/2011 | US7935685 Process for preparation of inclusion compounds between a non-steroidal anti-inflammatory drug and betacyclodextrin by microwave treatment |
| 05/03/2011 | US7935684 Method for treating allergic diseases |
| 05/03/2011 | US7935683 Nanoparticle comprising glucan backbone structure for use in detecting/screening for lectins in solutions |
| 05/03/2011 | US7935682 Wound healing dressing for enhancing fibrocyte formation |
| 05/03/2011 | US7935681 Antiviral nucleosides |
| 05/03/2011 | US7935680 Methods for modulating the axonal growth of central nervous system neurons |
| 05/03/2011 | US7935675 Immunostimulatory nucleic acid molecules |
| 05/03/2011 | US7935674 Indole derivatives |
| 05/03/2011 | US7935673 Polyphenol glycoside isolated from acerola |
| 05/03/2011 | US7935672 Derivatives of genkwanin and sakuranetin, cosmetic and therapeutic use thereof and preparation method of same |
| 05/03/2011 | US7935510 Modulating the expression of a gene in a host cell for applications such as gene therapy, large scale production of proteins and antibodies, cell-based high throughput screening assays, functional genomics and regulation of traits in transgenic organisms |
| 05/03/2011 | US7935377 Crystals of free (2R, 4R)-monatin and use thereof |
| 05/03/2011 | US7935367 Compositions and methods for increasing adipose metabolism, lipolysis or lipolytic metabolism via thermogenesis |
| 05/03/2011 | US7935365 Glycerophospholipids for the improvement of cognitive functions |
| 05/03/2011 | US7935361 Polyacrylamide hydrogel as a soft tissue filler endoprosthesis |
| 05/03/2011 | US7935359 Decoloring skin blemishes; nontoxic, nonirritating, nonallergenic |
| 05/03/2011 | US7935351 Use of CPG oligodeoxynucleotides to induce angiogenesis |
| 05/03/2011 | US7935346 Medicament for the two-step perioperative therapy of solid tumours |
| 05/03/2011 | US7935339 Inhibition of the CD95 ligand/receptor system for the treatment of neurological disorders and injuries |
| 05/03/2011 | US7935333 Vaccine against brain protein; antiepileptic agents |
| 05/03/2011 | US7935332 Presbyopia treatment by lens alteration |
| 05/03/2011 | CA2639210C Dibenzo (b,f) azepine intermediates |
| 05/03/2011 | CA2631581C Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity |
| 05/03/2011 | CA2629865C 2,3,4,5-tetrahydroxy-6-sulfooxy hexanoic acid pharmaceutically acceptable salts and equilibrium forms thereof, processes for their preparation, prarmaceutical compositions comprising such compounds and their medical use |
| 05/03/2011 | CA2622975C Adenosine a3 receptor agonists for the treatment of dry eye disorders |
| 05/03/2011 | CA2617351C Diltiazem controlled release formulation and method of manufacture |
| 05/03/2011 | CA2599890C Substituted pyridine derivatives |
| 05/03/2011 | CA2590860C Estrogen receptor modulators |
| 05/03/2011 | CA2582734C Dimeric small molecule potentiators of apoptosis |
| 05/03/2011 | CA2578714C Compositions comprising 5-amino-2-hydroxybenzoic acid and a reducing sugar |
| 05/03/2011 | CA2576067C Diarylmethyl piperazine derivatives, preparations thereof and uses thereof |
| 05/03/2011 | CA2557184C Pyrazolotriazines as kinase inhibitors |
| 05/03/2011 | CA2556757C Oxydecahydronaphthalene modulators of hm74 |
| 05/03/2011 | CA2554550C Hydroisoindoline tachykinin receptor antagonists |
| 05/03/2011 | CA2551789C Neutral endopeptidase (nep) and human soluble endopeptidase (hsep) inhibitors for prophylaxis and treatment of neurodegenerative disorders |
| 05/03/2011 | CA2539029C Method of inhibiting alveolar bone resorption and periodontal membrane loss and composition for internal use to be used therein |